275 related articles for article (PubMed ID: 7960222)
1. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
Wang LD; Shi ST; Zhou Q; Goldstein S; Hong JY; Shao P; Qiu SL; Yang CS
Int J Cancer; 1994 Nov; 59(4):514-9. PubMed ID: 7960222
[TBL] [Abstract][Full Text] [Related]
2. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
Wang LD; Zhou Q; Yang CS
J Cell Biochem Suppl; 1997; 28-29():159-65. PubMed ID: 9589362
[TBL] [Abstract][Full Text] [Related]
3. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.
Chen H; Wang LD; Guo M; Gao SG; Guo HQ; Fan ZM; Li JL
World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern China.
Dong Wang L; Bin Yue W; Zhou Y; Wei Feng C; Liu B; Zhou Q; Ying Jia Y; Zheng S; Gao SS; Ji Xie X; Min Fan Z; Min Niou H; Hao Zhuang Z; Yang CS; Min Bai Y; Jun Qi Y
Dis Esophagus; 2002; 15(1):80-4. PubMed ID: 12060048
[TBL] [Abstract][Full Text] [Related]
5. Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.
Xing Y; Ning Y; Ru LQ; Wang LD
World J Gastroenterol; 2003 Jul; 9(7):1601-3. PubMed ID: 12854173
[TBL] [Abstract][Full Text] [Related]
6. Changes of TGFbeta1 and TGFbetaRII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China.
Zhou Q; Dong Wang L; Du F; Zhou Y; Rui Zhang Y; Liu B; Wei Feng C; Gao SS; Fan ZM; Yang CS; Zheng S
Dis Esophagus; 2002; 15(1):74-9. PubMed ID: 12060047
[TBL] [Abstract][Full Text] [Related]
7. Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression.
Kimos MC; Wang S; Borkowski A; Yang GY; Yang CS; Perry K; Olaru A; Deacu E; Sterian A; Cottrell J; Papadimitriou J; Sisodia L; Selaru FM; Mori Y; Xu Y; Yin J; Abraham JM; Meltzer SJ
Int J Cancer; 2004 Sep; 111(3):415-7. PubMed ID: 15221970
[TBL] [Abstract][Full Text] [Related]
8. Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus.
Safatle-Ribeiro AV; Ribeiro U; Sakai P; Clarke MR; Fylyk SN; Ishioka S; Gama-Rodrigues J; Finkelstein SD; Reynolds JC
Cancer Detect Prev; 2000; 24(1):13-23. PubMed ID: 10757119
[TBL] [Abstract][Full Text] [Related]
9. Changes in p53 and Waf1p21 expression and cell proliferation in esophageal carcinogenesis.
Wang LD; Yang WC; Zhou Q; Xing Y; Jia YY; Zhao X
World J Gastroenterol; 1997 Jun; 3(2):87-9. PubMed ID: 27041952
[TBL] [Abstract][Full Text] [Related]
10. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions: study of a high-risk population in northern China.
Wang LD; Zhou Q; Yang WC; Yang CS
Anticancer Res; 1999; 19(1A):369-74. PubMed ID: 10226569
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features.
Feng CW; Wang LD; Jiao LH; Liu B; Zheng S; Xie XJ
BMC Cancer; 2002 Apr; 2():8. PubMed ID: 11978184
[TBL] [Abstract][Full Text] [Related]
13. Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.
Mitsunaga SI; Zhang SY; Ruggeri BA; Gimenez-Conti I; Robles AI; Conti CJ; Klein-Szanto AJ
Carcinogenesis; 1995 Jul; 16(7):1629-35. PubMed ID: 7542177
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
[TBL] [Abstract][Full Text] [Related]
16. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
[TBL] [Abstract][Full Text] [Related]
17. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
Krishnadath KK; Tilanus HW; van Blankenstein M; Bosman FT; Mulder AH
J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats.
Pera M; Fernandez PL; Pera M; Palacín A; Cardesa A; Dasenbrock C; Tillman T; Mohr U
Carcinogenesis; 2001 Feb; 22(2):271-7. PubMed ID: 11181448
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
